Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.

Gerda Trutnovsky; Olaf Reich; Elmar A Joura; Magdalena Holter; Alexandra Ciresa-König; Andreas Widschwendter; Christian Schauer; Gerhard Bogner; Ziga Jan; Angelika Boandl; Martin S Kalteis; Sigrid Regauer; Karl Tamussino

doi:10.1016/S0140-6736(22)00469-X

Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.

Gerda Trutnovsky, Olaf Reich, Elmar A Joura, Magdalena Holter, Alexandra Ciresa-König, Andreas Widschwendter, Christian Schauer, Gerhard Bogner (Co-author), Ziga Jan, Angelika Boandl, Martin S Kalteis, Sigrid Regauer, Karl Tamussino

Department of Obstetrics and Gynecology

Research output: Contribution to journal › Original Article › peer-review

36 Citations (Web of Science)

Original language	English
Pages (from-to)	1790-1798
Journal	LANCET
Volume	399
Issue number	10337
DOIs	https://doi.org/10.1016/S0140-6736(22)00469-X
Publication status	Published - 2022

Keywords

NATURAL-HISTORY
RISK-FACTORS
PROGRESSION
LESIONS
IMPACT

Access to Document

10.1016/S0140-6736(22)00469-X

Cite this

Trutnovsky, G., Reich, O., Joura, E. A., Holter, M., Ciresa-König, A., Widschwendter, A., Schauer, C., Bogner, G., Jan, Z., Boandl, A., Kalteis, M. S., Regauer, S., & Tamussino, K. (2022). Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial. LANCET , 399(10337), 1790-1798. https://doi.org/10.1016/S0140-6736(22)00469-X

Trutnovsky, Gerda ; Reich, Olaf ; Joura, Elmar A et al. / Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial. In: LANCET 2022 ; Vol. 399, No. 10337. pp. 1790-1798.

@article{74efe336db8f4149af8528d4acf43b6d,

title = "Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.",

keywords = "NATURAL-HISTORY, RISK-FACTORS, PROGRESSION, LESIONS, IMPACT",

author = "Gerda Trutnovsky and Olaf Reich and Joura, \{Elmar A\} and Magdalena Holter and Alexandra Ciresa-K{\"o}nig and Andreas Widschwendter and Christian Schauer and Gerhard Bogner and Ziga Jan and Angelika Boandl and Kalteis, \{Martin S\} and Sigrid Regauer and Karl Tamussino",

note = "Bogner: Department of Obstetrics and Gynaecology, Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2022",

doi = "10.1016/S0140-6736(22)00469-X",

language = "English",

volume = "399",

pages = "1790--1798",

journal = "LANCET ",

issn = "0140-6736",

publisher = "Elsevier ",

number = "10337",

}

Trutnovsky, G, Reich, O, Joura, EA, Holter, M, Ciresa-König, A, Widschwendter, A, Schauer, C, Bogner, G, Jan, Z, Boandl, A, Kalteis, MS, Regauer, S & Tamussino, K 2022, 'Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.', LANCET , vol. 399, no. 10337, pp. 1790-1798. https://doi.org/10.1016/S0140-6736(22)00469-X

Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial. / Trutnovsky, Gerda; Reich, Olaf; Joura, Elmar A et al.
In: LANCET , Vol. 399, No. 10337, 2022, p. 1790-1798.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.

AU - Trutnovsky, Gerda

AU - Reich, Olaf

AU - Joura, Elmar A

AU - Holter, Magdalena

AU - Ciresa-König, Alexandra

AU - Widschwendter, Andreas

AU - Schauer, Christian

AU - Bogner, Gerhard

AU - Jan, Ziga

AU - Boandl, Angelika

AU - Kalteis, Martin S

AU - Regauer, Sigrid

AU - Tamussino, Karl

N1 - Bogner: Department of Obstetrics and Gynaecology, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - NATURAL-HISTORY

KW - RISK-FACTORS

KW - PROGRESSION

KW - LESIONS

KW - IMPACT

U2 - 10.1016/S0140-6736(22)00469-X

DO - 10.1016/S0140-6736(22)00469-X

M3 - Original Article

C2 - 35483400

SN - 0140-6736

VL - 399

SP - 1790

EP - 1798

JO - LANCET

JF - LANCET

IS - 10337

ER -

Trutnovsky G, Reich O, Joura EA, Holter M, Ciresa-König A, Widschwendter A et al. Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial. LANCET . 2022;399(10337):1790-1798. doi: 10.1016/S0140-6736(22)00469-X